Exane BNP Paribas downgraded RH (RH) to Underperform from Neutral with a price target of $253, down from $274. The company’s leverage and liquidity shorten the timeframe for it to deliver results, the ...
Exane BNP Paribas downgraded RH (RH) to Underperform from Neutral with a $253 price target The firm sees a negative risk/reward skew with significant downside to consensus estimates. Published first ...
The S&P 500 Index ($SPX) (SPY) today is up +0.04%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.27%, and the Nasdaq ...
Exane BNP Paribas has recently raised BILL Holdings Inc (BILL) stock to Outperform rating, as announced on September 12, 2024, according to Finviz. Earlier, on August 26, 2024, BMO Capital Markets had ...
Emerson Electric (EMR) is up more than +1% after BNP Paribas Exane initiated coverage on the stock with a recommendation of ...
Real-time index price for TSX 60 Equal Weight Index (TXEW), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
BNP Paribas Exane upgraded Schroders on Friday to ‘outperform’ from ‘neutral’ ahead of third-quarter results next week, as it ...
Earlier, on June 11, 2024, Exane BNP Paribas had raised the stock from a Underperform to Neutral. Barclays also raised Overweight rating with a price target of $20. Additionally, Wolfe Research raised ...
Fintel reports that on October 8, 2024, Exane BNP Paribas initiated coverage of Samsara (NYSE:IOT) with a Neutral recommendation. As of September 25, 2024, the average one-year price target for ...
Fintel reports that on October 1, 2024, Exane BNP Paribas initiated coverage of NextEra Energy Partners, LP - Limited Partnership (NYSE:NEP) with a Underperform recommendation. As of September 25 ...
(Alliance News) - Applied Nutrition PLC on Tuesday announced its set price range being targeted for its planned initial public offering this month. (Sharecast News) - JD Sports Fashion's share ...
On Wednesday, BNP Paribas (OTC:BNPQY) Exane updated its stance on Qorvo Inc (NASDAQ:QRVO) shares, downgrading the stock from Outperform to Neutral, while setting a price target of $80.00. The firm's ...